Dilevalol hydrochloride
- Level
- Commodity
- Parent
- 51411600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51411614This classification denotes a vasodilating agent and adrenergic antagonist with the molecular structure C19H24N2O3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, O5OBT75D2C chemically known as benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride, (r-(r*,r*))-, but more commonly known as dilevalol hydrochloride, which bears US NIH Compound Identifier 636407. European Medicines Agency schedules Dilevalol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01734MIG. Most nations, for tariff and trade purposes, schedule dilevalol hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, DILEVALOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CCC1CCCCC1)NC[C@@H](C2CCC(C(C2)C(=O)N)O)O.CL.
Same parent
Under 51411600 · 15Activities that produce or sell this
KBLI · 8Inherited from family 51410000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.